Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Moreland

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Biochemical Pharmacology|July 28, 2004
Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5)Robert B Moreland, Masaki Nakane, Diana L Donnelly-Roberts, et al.
Neurosurgery|July 23, 2024
First Reported Series of Cerebral Angiography Performed at an Outpatient Center: Safety and Satisfaction ResultsTyler A Scullen, Ming X Lian, Vinay Jaikumar, et al.
Frontiers in Urology|August 8, 2025
Beyond the usual suspects: emerging uropathogens in the microbiome ageRobert B Moreland, Brian I Choi, Wilson Geaman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2004
Activation of dopamine D4 receptors by ABT-724 induces penile erection in ratsJorge D Brioni, Robert B Moreland, Marlon Cowart, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2007
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptorBruce R Bianchi, Rachid El Kouhen, Torben R Neelands, et al.
Journal of Medicinal Chemistry|November 11, 2005
Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Jerome Daanen, et al.
Bioorganic & Medicinal Chemistry|May 18, 2005
Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonistsXueqing Wang, Pramila A Bhatia, Jerome F Daanen, et al.
Neuropharmacology|July 5, 2005
2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonistMasaki Nakane, Marlon D Cowart, Gin C Hsieh, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2006
Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Teodozyj Kolasa, et al.
Journal of Biomolecular Screening|November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonistsJun Chen, Marc R Lake, Reza S Sabet, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Biochemical Pharmacology|July 28, 2004
Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5)Robert B Moreland, Masaki Nakane, Diana L Donnelly-Roberts, et al.
Neurosurgery|July 23, 2024
First Reported Series of Cerebral Angiography Performed at an Outpatient Center: Safety and Satisfaction ResultsTyler A Scullen, Ming X Lian, Vinay Jaikumar, et al.
Frontiers in Urology|August 8, 2025
Beyond the usual suspects: emerging uropathogens in the microbiome ageRobert B Moreland, Brian I Choi, Wilson Geaman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2004
Activation of dopamine D4 receptors by ABT-724 induces penile erection in ratsJorge D Brioni, Robert B Moreland, Marlon Cowart, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 31, 2007
[3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptorBruce R Bianchi, Rachid El Kouhen, Torben R Neelands, et al.
Journal of Medicinal Chemistry|November 11, 2005
Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Jerome Daanen, et al.
Bioorganic & Medicinal Chemistry|May 18, 2005
Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonistsXueqing Wang, Pramila A Bhatia, Jerome F Daanen, et al.
Neuropharmacology|July 5, 2005
2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonistMasaki Nakane, Marlon D Cowart, Gin C Hsieh, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 2006
Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonistsGuo Zhu Zheng, Pramila Bhatia, Teodozyj Kolasa, et al.
Journal of Biomolecular Screening|November 14, 2006
Utility of large-scale transiently transfected cells for cell-based high-throughput screens to identify transient receptor potential channel A1 (TRPA1) antagonistsJun Chen, Marc R Lake, Reza S Sabet, et al.
Pageof 13